1 / 4

Global Gastric Cancer Market Share, Size, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027

Global Gastric Cancer Market Size, Share & Trends Analysis Report by Testing Type (Chest X-Ray, Computed Tomography (CT OR CAT) Scan, Laparoscopy, MRI Scan, PET Scan, and Others) By Treatment Type (Chemotherapy, Radiation Therapy, Surgery, Targeted Therapy, and Immunotherapy) By End-User (Hospitals & Clinics, Specialized Cancer Treatment Centers, and Others) Forecast 2021-2027<br>

rishabh3210
Download Presentation

Global Gastric Cancer Market Share, Size, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Orion Market Research Global Gastric Cancer Market Share, Size, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027 Market: Request https://www.omrglobal.com/request-sample/gastric-cancer-market a Free Sample of our Report on Gastric Cancer Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The global gastric cancer market is anticipated to grow at a modest CAGR of around 6.8% during the forecast period (2021-2027). The rising prevalence of gastric cancer and the growing geriatric population is the major factor driving the growth of the market. According to the American Cancer Society, stomach cancer accounts for about 1.5% of all new cancers diagnosed in the US each year. Stomach cancer mostly affects older people. The average age of people when they are diagnosed is 68. About 6 of every 10 people diagnosed with stomach cancer each year are 65 or older. According to WHO, approx. 800,000 cancer-related death are caused by gastric cancer every year. Due to the increase in the number of gastric cancer cases, the demands for advanced and effective treatments increase, which positively affected the market growth. Additionally, the new combined therapies also proved best for the cancer treatments, such as when chemotherapy combined with radiation therapy gives better results. (Get 15% Discount on Buying this Report) Get Report Sample Copy @ https://www.omrglobal.com/request-sample/gastric-cancer- market The rising FDA approvals for cancer treatments drugs is the major factor that is expected to increase these drug demands and will offer various opportunities to manufacturers. For instance, in April 2021, the FDA approved Nivolumab in combination with certain types of chemotherapy for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma. Moreover, in January 2021, the FDA approved Enhertu (trastuzumab deruxtecan) drug, produced by AstraZeneca and Daiichi Sankyo Co., Ltd, for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric cancer. Considering these FDA approvals, considerable growth can be expected in the global gastric cancer market during the forecast period. A https://www.omrglobal.com/industry-reports/gastric-cancer-market Full Report of Global Gastric Cancer Market is Available at: Key questions addressed by the report •What is the market growth rate? •Which segment and region dominate the market in the base year? •Which segment and region will project the fastest growth in the market? •How COVID-19 impacted the market? o Deviation from the pre-COVID-19 forecast o Most affected region and segment •Who is the leader in the market? •How players are addressing challenges to sustain growth? •Where is the investment opportunity?

  3. Global Gastric Cancer Market Report Segment By Testing Type •Chest X-Ray •Computed Tomography (CT OR CAT) Scan •Laparoscopy •Magnetic Resonance Imaging (MRI) Scan •Positron Emission Tomography (PET) Scan •Others (Upper Gastrointestinal (GI) Series) By Treatment Type •Chemotherapy •Radiation Therapy •Surgery •Targeted Therapy •Immunotherapy By End-Users •Hospitals & Clinics •Specialized Cancer Treatment Centers •Others (Ambulatory Surgical Centers) Global Gastric Cancer Market Report Segment by Region North America •United States •Canada Europe •UK •Germany •Italy •Spain •France •Russia •Rest of Europe Asia-Pacific

  4. •China •India •Japan •South Korea •Rest of Asia-Pacific Rest of the World Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For https://www.omrglobal.com/industry-reports/gastric-cancer-market More Customized Data, Request for Report Customization @ About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 780-304-0404

More Related